{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:48:52Z","timestamp":1789951732116,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.biopha.2018.06.081","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T03:34:52Z","timestamp":1529552092000},"page":"1133-1140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Long non-coding RNA HOTTIP is upregulated in renal cell carcinoma and regulates cell growth and apoptosis by epigenetically silencing of LATS2"],"prefix":"10.1016","volume":"105","author":[{"given":"Feifei","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangchi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.06.081_bib0005","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(09)60229-4","article-title":"Renal cell carcinoma","volume":"373","author":"Rini","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2018.06.081_bib0010","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrurol.2014.194","article-title":"Landmarks in the diagnosis and treatment of renal cell carcinoma","volume":"11","author":"Bhatt","year":"2014","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.biopha.2018.06.081_bib0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2007.12.001","article-title":"Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review","volume":"34","author":"Gupta","year":"2008","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.biopha.2018.06.081_bib0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11864-018-0522-4","article-title":"Overview of current and future adjuvant therapy for high-risk localized renal cell carcinoma","volume":"19","author":"Nandagopal","year":"2018","journal-title":"Curr. Treat. Opt. Oncol."},{"key":"10.1016\/j.biopha.2018.06.081_bib0025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.eururo.2017.07.017","article-title":"The risk of tumour recurrence in patients undergoing renal transplantation for end-stage renal disease after previous treatment for a urological cancer: a systematic review","volume":"73","author":"Boissier","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.biopha.2018.06.081_bib0030","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.canlet.2016.03.003","article-title":"Long non-coding RNA: a newly deciphered code in prostate cancer","volume":"375","author":"Zhang","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2018.06.081_bib0035","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4161\/rna.20481","article-title":"The hallmarks of cancer: a long non-coding RNA point of view","volume":"9","author":"Gutschner","year":"2012","journal-title":"RNA Biol."},{"key":"10.1016\/j.biopha.2018.06.081_bib0040","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08975","article-title":"Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis","volume":"464","author":"Gupta","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2018.06.081_bib0045","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1038\/onc.2010.568","article-title":"Long noncoding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15 (INK4B) tumor suppressor gene","volume":"30","author":"Kotake","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2018.06.081_bib0050","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1158\/0008-5472.CAN-14-2931","article-title":"Long noncoding RNA MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and interacts with miR-205","volume":"75","author":"Hirata","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2018.06.081_bib0055","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.gene.2017.06.021","article-title":"The association of rs710886 in lncRNA PCAT1 with bladder cancer risk in a Chinese population","volume":"627","author":"Lin","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.biopha.2018.06.081_bib0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.gene.2017.04.036","article-title":"Association of a novel genetic variant in RP11-650L12.2 with risk of colorectal cancer in han Chinese population","volume":"624","author":"Jin","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.biopha.2018.06.081_bib0065","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.bbrc.2016.08.120","article-title":"The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition","volume":"480","author":"Zheng","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2018.06.081_bib0070","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.biopha.2017.01.004","article-title":"Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p","volume":"87","author":"Zhang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.06.081_bib0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13046-018-0747-x","article-title":"SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2\/LSD1\/DNMT1 and sponging miR-101-3p in cholangiocarcinoma","volume":"37","author":"Xu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2018.06.081_bib0080","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s12885-017-3339-9","article-title":"An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma","volume":"17","author":"Xu","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2018.06.081_bib0085","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nature09819","article-title":"A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2018.06.081_bib0090","doi-asserted-by":"crossref","first-page":"10840","DOI":"10.18632\/oncotarget.3450","article-title":"The long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migration","volume":"6","author":"Cheng","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2018.06.081_bib0095","article-title":"LncRNA HOTTIP-mediated HOXA11 expression promotes cell growth, migration and inhibits cell apoptosis in breast cancer","volume":"19","author":"Sun","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2018.06.081_bib0100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41419-017-0113-5","article-title":"Long non-coding RNA HOTTIP promotes BCL-2 expression and induces chemoresistance in small cell lung cancer by sponging miR-216a","volume":"9","author":"Sun","year":"2018","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.biopha.2018.06.081_bib0105","doi-asserted-by":"crossref","first-page":"95108","DOI":"10.18632\/oncotarget.19345","article-title":"LncRNA MALAT1, HOTTIP and PVT1 as predictors for predicting the efficacy of GEM based chemotherapy in first-line treatment of pancreatic cancer patients","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2018.06.081_bib0110","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11912-018-0684-z","article-title":"Current and emerging therapeutic targets for metastatic renal cell carcinoma","volume":"20","author":"Zarrabi","year":"2018","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.biopha.2018.06.081_bib0115","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3322\/caac.21411","article-title":"Treatment of renal cell carcinoma: current status and future directions","volume":"67","author":"Barata","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2018.06.081_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biocel.2018.02.013","article-title":"LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637","volume":"98","author":"Yuan","year":"2018","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"10.1016\/j.biopha.2018.06.081_bib0125","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.biopha.2017.12.064","article-title":"Knockdown of the long non-coding RNA HOTTIP inhibits colorectal cancer cell proliferation and migration and induces apoptosis by targeting SGK1","volume":"98","author":"Liu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.06.081_bib0130","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1158\/1535-7163.MCT-05-0448","article-title":"Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells","volume":"5","author":"Mantena","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2018.06.081_bib0135","first-page":"3253","article-title":"Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma","volume":"54","author":"Dole","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2018.06.081_bib0140","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1126\/science.270.5233.96","article-title":"Bax-deficient mice with lymphoid hyperplasia and male germ cell death","volume":"270","author":"Knudson","year":"1995","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.biopha.2018.06.081_bib0145","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ymthe.2017.01.017","article-title":"Long noncoding RNA LINC00673 is activated by SP1 and exerts oncogenic properties by interacting with LSD1 and EZH2 in gastric cancer","volume":"25","author":"Huang","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2018.06.081_bib0150","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1158\/0008-5472.CAN-16-0356","article-title":"LncRNA HOXA11-AS promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors PRC2, LSD1, and DNMT1","volume":"76","author":"Sun","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2018.06.081_bib0155","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.4161\/cc.9.19.13386","article-title":"LATS tumor suppressor: a new governor of cellular homeostasis","volume":"9","author":"Visser","year":"2010","journal-title":"ABBV Cell Cycle"},{"key":"10.1016\/j.biopha.2018.06.081_bib0160","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1158\/1078-0432.CCR-04-1773","article-title":"Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers","volume":"11","author":"Takahashi","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2018.06.081_bib0165","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13046-017-0622-1","article-title":"Downregulation of miR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma","volume":"36","author":"Gao","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218326866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218326866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T16:42:09Z","timestamp":1731429729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218326866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":33,"alternative-id":["S0753332218326866"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.06.081","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long non-coding RNA HOTTIP is upregulated in renal cell carcinoma and regulates cell growth and apoptosis by epigenetically silencing of LATS2","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.06.081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}